Demiurge is a world-leading Swiss artificial intelligence, neuroscience, and pharmaceutical company with a focus on translating exponentially growing neuroscience data into a new generation of deep neural networks (Deep Learning 2.0) whose learning performance and learning efficiency match those of animal brains.
Demiurge Technologies develops the next generation of neural networks and mobile robots from a rebuilt foundation of mathematics, neuroscience and medicine, to realize one-shot learning and self-supervised learning for ultra-safe fully autonomous cars on earth and low-cost exploratory robots in space.
Demiurge Technologies was founded in 2015 by Idonae Lovetrue & Bragi Lovetrue and is based in Zug, Zug, Switzerland.
Demiurge Technologies discovers the first principles of neural networks for mobile agents by bridging deep learning and neuroscience.
Demiurge's Deep Learning 2.0 is the enabling technology of not only breakthrough pharma products that could spare the 1 billion aging population from neurodegenerative diseases and brain disorders, such as and Alzheimer's and Parkinson's diseases but also breakthrough physical AI products that could meet the exponentially growing market demand for time-saving autonomous robots under real-world constraints on earth and in space.
Demiurge Technologies applies the algorithmic insights of the next generation of neural networks to replacing the inefficient blind-men-and-an-elephant-style data-driven approach to drug discovery with an efficient solving-a-billion-piece-puzzle-style hypothesis-driven approach, making meticulous and audacious strides towards reversing and curing diseases of great unmet needs.
Demiurge was elected among the 50 most influential companies of the Swiss digital economy. It is also recognized by the International Telecommunication Union (ITU) as a world leader in integrating AI technologies for smart cities.